Tilganga Institute of Ophthalmology Gets $930 Thousand Grant to Double IOL Production

May 11, 2018: By Joan McKenna

The Tilganga Institute of Ophthalmology in Nepal has received a $930 thousand government grant ($100 million Nepalese rupees) to double production capacity for intraocular lenses, the institute announced May 10.

Tilganga said in 2017 that it produced lenses at a rate of 500 thousand per year, with a total of 4.9 million IOLs sold in more than 50 countries since it opened its doors in 1994.

Nepal native Sanduk Ruit, MD, helped found Tilganga with the mission to provide high-quality care in places considered poor by Western standards. The facility’s lenses cost as little as $3.

Ruit waives surgery fees for those unable to pay and treks to remote parts of Nepal and throughout the Himalayas to treat patients who can’t travel to the facility. Ruit and colleagues from Tilganga have traveled as far as North Korea, Cambodia, Bangladesh, Vietnam, Ethiopia, and Ghana.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Aerie Submits NDA for Roclatan to US FDA

Surface Raises $20 Million in Series A Financing from Flying L Partners

iSTAR Announces ‘Promising’ Early-Stage Results for MINIject MIGS Device

Carl Zeiss Meditec Revenues Total $723.8 Million in the First Half of FY2018, a 4.5 Percent Increase

Moorfields Team Develops Drink-Based Dye for Diagnosing Retinal Disease in Children

Supreme Court Upholds Inter Partes Review Process for Challenging Patents

Study Indicates Ophthalmology Residents Face High Burden of Burnout, Depression

Takeda Makes Firm $62.2 Billion Bid for Shire

Valeant to Rebrand as Bausch Health Companies in July

Hoya Receives CE Mark for Vivinex IOL with 4-in-1 MultiSert Preloaded Delivery System

Tilganga Institute of Ophthalmology Gets $930 Thousand Grant to Double IOL Production

Abpro Postpones $60 Million IPO; Company Has Anti-VEGF/ANG-2 Product Candidate

Valeant Reports Q1-2018 Revenues of $1.9 Billion, a Decline of 5 Percent

Glaukos’ Net Sales Grow 12 Percent in Q1-2018

Second Sight Reports 16 Argus II Implants in Q1-2018

Omeros’ Omidria Revenues Drop 86 Percent in Q1-2018; Company Attributes Decline to Temporary Loss of Pass-through Status

Bausch + Lomb Starts Clinical Trial for New Ophthalmic Viscosurgical Device

NEI Awards LayerBio $1.2 Million to Develop Sustained-Release Glaucoma Drug

Bausch + Lomb Launches Lumify, OTC Eye Drop with Low-Dose Brimonidine for Ocular Redness

Aerie Launches Rhopressa in US as Treatment for Lowering IOP

Coming soon

2018 Cataract Surgical Equipment Report: A Global Market Analysis for 2017 to 2023